Dermot Maher

ORCID: 0000-0003-0466-1976
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • HIV/AIDS Impact and Responses
  • HIV/AIDS Research and Interventions
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Global Maternal and Child Health
  • Diagnosis and treatment of tuberculosis
  • Global Public Health Policies and Epidemiology
  • Adolescent Sexual and Reproductive Health
  • Health Systems, Economic Evaluations, Quality of Life
  • HIV, Drug Use, Sexual Risk
  • Infectious Diseases and Tuberculosis
  • Health Policy Implementation Science
  • Global Health and Surgery
  • Pneumonia and Respiratory Infections
  • Mycobacterium research and diagnosis
  • HIV Research and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Primary Care and Health Outcomes
  • Neutropenia and Cancer Infections
  • Poverty, Education, and Child Welfare
  • Sex work and related issues
  • HIV-related health complications and treatments
  • Community Development and Social Impact
  • Immunotherapy and Immune Responses
  • Genetics, Bioinformatics, and Biomedical Research

University of Pittsburgh
2024

Ain Shams University
2024

Special Programme for Research and Training in Tropical Diseases
2016-2023

Australia and New Zealand Banking Group
2022

Drugs for Neglected Diseases Initiative
2021

World Health Organization
2004-2020

United Nations Children's Fund India
2020

Johns Hopkins Hospital
2019-2020

Hospital for Tropical Diseases
2018-2020

Johns Hopkins University
2020

Respondent-driven sampling is a novel variant of link-tracing for estimating the characteristics hard-to-reach groups, such as HIV prevalence in sex workers. Despite its use by leading health organizations, performance this method realistic situations still largely unknown. We evaluated respondent-driven comparing estimates from survey with total population data.Total data on age, tribe, religion, socioeconomic status, sexual activity, and status were available 2402 male household heads an...

10.1097/ede.0b013e31823ac17c article EN Epidemiology 2011-12-13

In patients who have not received extensive prior chemotherapy or radiotherapy, it has been previously demonstrated that granulocyte colony-stimulating factor (G-CSF) abrogated the leukopenia following administration of melphalan (25 mg/m2). This study examined necessity a prechemotherapy period G-CSF and effect varying timing duration postchemotherapy G-CSF. Initially, 0.3, 1.0, 3.0, 10 micrograms/kg/d subcutaneously on days 1 to 5 18. Melphalan was given day 9. next portion administered...

10.1200/jco.1989.7.10.1554 article EN Journal of Clinical Oncology 1989-10-01

The General Population Cohort (GPC) was set up in 1989 to examine trends HIV prevalence and incidence, their determinants rural south-western Uganda. Recently, the research questions have included epidemiology genetics of communicable non-communicable diseases (NCDs) address limited data on burden risk factors for NCDs sub-Saharan Africa. cohort comprises all residents (52% aged ≥13years, men women equal proportions) within one-half a sub-county, residing scattered houses, largely farmers...

10.1093/ije/dys234 article EN International Journal of Epidemiology 2013-01-30

Sub-Saharan Africa is undergoing health transition as increased globalization and accompanying urbanization are causing a double burden of communicable noncommunicable diseases. Rates diseases such HIV/AIDS, tuberculosis malaria in the highest world. The impact also increasing. For example, age-standardized mortality from cardiovascular disease may be up to three times higher some African than European countries. As entry point into service for most people, primary care plays key role...

10.2471/blt.10.077891 article EN cc-by Bulletin of the World Health Organization 2010-12-01

The prevalence of diabetes mellitus is increasing at a dramatic rate, and countries in Asia, particularly India China, will bear the brunt this epidemic. Persons with have significantly increased risk active tuberculosis (TB), which two to three times higher than persons without diabetes. In article, we argue that epidemiological interactions effects on clinical presentation treatment resulting from interaction between TB are similar those observed for human immunodeficiency virus (HIV) TB....

10.5588/ijtld.11.0503 article EN The International Journal of Tuberculosis and Lung Disease 2011-09-20

The growing global burden of non communicable diseases (NCDs) is now killing 36 million people each year and needs urgent comprehensive action. This article provides an overview key critical issues that need to be resolved ensure recent political commitments are translated into practical These include: (i) categorizing prioritizing NCDs in order inform donor funding priorities for intervention; (ii) finding the right balance between relative importance treatment prevention responses cover...

10.1186/1744-8603-8-14 article EN cc-by Globalization and Health 2012-06-11

Data on non-communicable disease (NCD) burden are often limited in developing countries Africa but crucial for planning and implementation of prevention control strategies. We assessed the prevalence related cardiovascular risk factors (hyperglycaemia, high blood pressure obesity) a longstanding population cohort rural Uganda.Trained field staff conducted cross-sectional population-based survey indicators using questionnaire simple measurements body mass index (BMI), waist hip circumference,...

10.1093/ije/dyq156 article EN cc-by-nc International Journal of Epidemiology 2010-10-05
Coming Soon ...